Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05727514 · ClinicalTrials.gov registry record · NA
Beyond COVID-19: Supporting Resilience With a Trauma-informed Music Composition Program
A NA study of Problems Related to Life-Management Difficulty, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT05727514: Completed NA study of Problems Related to Life-Management Difficulty, sponsored by Brigham and Women's Hospital.
NCT05727514 is a NA study of Problems Related to Life-Management Difficulty that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05727514, a NA study of Problems Related to Life-Management Difficulty, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study explores the feasibility and acceptability of a music composition intervention to support resilience in survivors of serious illness hospitalized during the COVID-19 pandemic.
Primary Outcome
The New General Self-Efficacy (NGSE) scale evaluates one's perception of their overall ability to perform successfully in a variety of common scenarios by rating each item from 1-"Strongly Disagree" to 5-"Strongly Agree". Responses were scored by averaging the ratings across items. Min possible score: 1 Max possible score: 5 Min study score: 3.125 Max study score: 5.00 Higher scores mean a better outcome.
Conditions Studied
Interventions
- OTHER music composition
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2023-02-01 |
| Phase | NA |
What the finished NCT05727514 record still lists
NCT05727514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Problems Related to Life-Management Difficulty appearing as the primary indexed condition, and to 1 intervention - of which music composition is the first listed.
NCT05727514 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05727514 about?
NCT05727514 is a clinical study titled "Beyond COVID-19: Supporting Resilience With a Trauma-informed Music Composition Program". This study explores the feasibility and acceptability of a music composition intervention to support resilience in survivors of serious illness hospitalized during the COVID-19 pandemic.
What is the current status of trial NCT05727514?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-04-22. Estimated completion is 2023-02-01.
What conditions does trial NCT05727514 study?
This clinical trial studies the following conditions: Problems Related to Life-Management Difficulty.
What interventions are being tested in trial NCT05727514?
The interventions under investigation include: music composition (OTHER).
Who is sponsoring clinical trial NCT05727514?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05727514 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05727514's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy